Laserfiche WebLink
or overdose fatality), and training of health care personnel to identify and address such <br /> trauma. <br /> 7. Support detoxification (detox) and withdrawal management services for persons with <br /> OUD and any co-occurring SUD/MH conditions, co-usage, and/or co-addiction, <br /> including medical detox, referral to treatment, or connections to other services or <br /> supports. <br /> 8. Support training on MAT for health care providers, students, or other supporting <br /> professionals, such as peer recovery coaches or recovery outreach specialists, <br /> including telementoring to assist community-based providers in rural or underserved <br /> areas. <br /> 9. Support workforce development for addiction professionals who work with persons <br /> with OUD and any co-occurring SUD/MH conditions, co-usage, and/or co-addiction. <br /> 10. Provide fellowships for addiction medicine specialists for direct patient care, <br /> instructors, and clinical research for treatments. <br /> 11. Provide funding and training for clinicians to obtain a waiver under the federal Drug <br /> Addiction Treatment Act of 2000 (DATA 2000) to prescribe MAT for OUD, and <br /> provide technical assistance and professional support to clinicians who have obtained <br /> a DATA 2000 waiver. <br /> 12. Support the dissemination of web-based training curricula, such as the American <br /> Academy of Addiction Psychiatry's Provider Clinical Support Service-Opioids web- <br /> based training curriculum and motivational interviewing. <br /> 13. Support the development and dissemination of new curricula, such as the American <br /> Academy of Addiction Psychiatry's Provider Clinical Support Service for <br /> Medication-Assisted Treatment. <br /> B. SUPPORT PEOPLE IN TREATMENT AND RECOVERY <br /> Support people in treatment for and recovery from OUD and any co-occurring SUD/MH <br /> conditions, co-usage, and/or co-addiction through evidence-based, evidence-informed, or <br /> promising programs or strategies that may include, but are not limited to, the following: <br /> 1. Provide the full continuum of care of recovery services for OUD and any co-occurring <br /> SUD/MH conditions, co-usage, and/or co-addiction, including supportive housing, <br /> residential treatment, medical detox services, peer support services and counseling, <br /> community navigators, case management, and connections to community-based <br /> services. <br /> 2. Provide counseling, peer-support, recovery case management and residential <br /> treatment with access to medications for those who need it to persons with OUD and <br /> any co-occurring SUD/MH conditions, co-usage, and/or co-addiction. <br /> 2 <br />